The case report that started conversations One case report deserves specific attention because it illustrates the potential
Comparative studies reveal that once-weekly exenatide exhibits the lowest risk of vomiting compared to all other formulations (Htike et al
Ozempic is FDA-approved to treat type 2 diabetes, in conjunction with diet and exercise changes
When to pause or reverse the taper Red flags that should pause your taper include weight gain exceeding 3% of your lowest weight, significant increase in hunger that interferes with daily functioning, worsening metabolic markers such as rising blood sugar, blood pressure, or lipid levels, return of binge eating patterns or loss-of-control eating episodes, and significant emotional distress related to appetite changes
Individuals with type 2 diabetes typically experience an impaired incretin effect, though GLP-1 secretion itself may be normal, slightly reduced, or context-dependent
Support steady, sustainable weight loss alongside nutrition and movement